Effectiveness, Cost-effectiveness, and Acceptability of Phone Call and Video-based Interventions to Improve Adherence to Antihypertensive Medications

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The goal of this clinical trial is to find out if phone call and video-based interventions that seek to educate people with uncontrolled high blood pressure and also remind them to take their medicines will improve adherence to their medicines. It will also examine if the interventions are economical to implement. The main objectives of the study are: * Design videos and phone call-based interventions for people with hypertension. * Examine the effect of videos and phone call-based intervention on adherence to medication in people with hypertension. * Calculate the costs associated with the mobile health intervention * Examine the factors influencing acceptance of video and phone calls based interventions for improving adherence to antihypertensive medications among patients Participants will: * Receive the intervention thrice weekly for 3 months * Visit the health facility at the end of 3 months for check up and measurement of outcome variables (adherence and blood pressure). Additionally, at the end of 3 months, the acceptability of the interventions will be measured among the participants who received either phone call or video. Researchers will compare the two groups (one group will utilize phone call whereas the other videos) with the control group to see if the mobile interventions improve adherence to medicines. Only adults 18 years and above in selected health facilities in the Eastern will participate in the study. The selected participants should have uncontrolled blood pressure based on readings from last 2 visits. To be included in the study, the participants need to own a smartphone.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• adult aged 18 years or older

• diagnosed of hypertension

• has uncontrolled hypertension (i.e. systolic blood pressure ≥140 mmHg and a diastolic blood pressure ≥ 90mmHg) documented in their records on 2 clinic visits

• has been prescribed at least one antihypertensive medication for a period of 2 months before the study

• owns a smart phone or has access to one at all times.

Locations
Other Locations
Ghana
St Joseph Catholic Hospital
RECRUITING
Efiduase
Contact Information
Primary
Grace Okai, MPhil
graforiwaa@yahoo.com
+233242889013
Backup
Gordon Abekah-Nkrumah, PhD
gabekah-nkrumah@ug.edu.gh
+233553122132
Time Frame
Start Date: 2025-02-24
Estimated Completion Date: 2025-08-30
Participants
Target number of participants: 1400
Treatments
Active_comparator: the video-group
In this arm, participants with uncontrolled blood pressure will receive videos via WhatsApp to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the video intervention in addition to usual care (which is the care they receive from health facilities)
Active_comparator: the phone call group
In this arm, participants with uncontrolled blood pressure will receive phone calls to educate them about the condition hypertension, side effects of medications and also remind them to take their medications. The intervention will be administered on days and time convenient for the patient and will be administered thrice weekly for 3 months. Participants in this group will receive the phone call intervention in addition to usual care (which is the care they receive from health facilities)
Placebo_comparator: control group
This group will neither receive phone call or videos. The group will only receive a message that indicates that they are being enrolled into the study.
Related Therapeutic Areas
Sponsors
Leads: University of Ghana

This content was sourced from clinicaltrials.gov